COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025
07/05/2025
7 May 2025 - Financial report for the period 1 January 2025 to 31 March 2025 Operating profit increased by 22% in Danish kroner and by 20% at constant exchange rates (CER) to DKK 38.8 billion. Sales in US Operations [...]
CROSSJECT provides updates on the EUA filing of ZEPIZURE®
07/05/2025
Press Release CROSSJECT provides updates on the EUA filing of ZEPIZURE® CROSSJECT and its EUROFINS CDMO partner successfully completed the aseptic filling of all ZEPIZURE® registration batches and anticipate the [...]
CROSSJECT fait un point sur les dernières avancées dans le dépôt de la demande EUA de ZEPIZURE®
07/05/2025
Communiqué de presse CROSSJECT fait un point sur les dernières avancées dans le dépôt de la demande EUA de ZEPIZURE® CROSSJECT et son partenaire EUROFINS ont achevé avec succès le remplissage aseptique de tous les lots [...]
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates
07/05/2025
Total revenues of €49.2 million compared to €32.8 million in the first quarter of 2024 Cash and cash equivalents of €153.0 million at end of March 2025 Further clinical and regulatory progress 2025 financial outlook [...]
Valneva publie ses résultats financiers du premier trimestre 2025 et fait un point sur son activité
07/05/2025
Chiffre d’affaires de 49,2 millions d’euros contre 32,8 millions d’euros au premier trimestre 2024 Trésorerie et équivalents de trésorerie de 153,0 millions d’euros à fin mars 2025 Poursuite des avancées cliniques et [...]
CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105
07/05/2025
First results of SCENESSE® study expected in 2H 2026 Executive summary Recruitment target of 200 vitiligo patients (Fitzpatrick skin type III-VI) in CUV105 study achieved Randomised trial, 20-week treatment protocol [...]
PrimeBiome Reviews Consumer Reports: Critical Complaints & Customer Reviews Exposed!
07/05/2025
ANCHORAGE, Alaska, May 07, 2025 (GLOBE NEWSWIRE) -- PrimeBiome is a natural skin and gut health formula that has been gaining immense popularity in the market. As per the claims of the manufacturers, this formula is [...]
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
07/05/2025
600-patient study to assess efficacy of rhu-pGSN, an immune system regulator that interrupts the NLRP3 inflammasome and boosts macrophage clearance of pathogens. Results from this landmark study expected to inform [...]
Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference
07/05/2025
Optigo wins People’s Choice Award at the recent Eyecelerator meeting in Park City for proprietary drug anchoring, potential to transform intravitreal drug delivery Preclinical data demonstrates sustained efficacy and [...]
Dogecoin Cash, Inc. Confirms Stock Dividend Record and Payment Dates; FINRA Publication Completed
07/05/2025
MESQUITE, NV, May 06, 2025 (GLOBE NEWSWIRE) -- March 10, 2025 – Mesquite, NV – Dogecoin Cash, Inc. ($CBDS), a publicly traded leader in blockchain innovation, is excited to announce its strategic expansion into the [...]
Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results
07/05/2025
Data from Phase 1b/2a RESOLVE suggests EP-104GI has significant potential to improve the standard of care for patients with Eosinophilic Esophagitis (EoE) Cash runway to fund operations out to third quarter of 2026 [...]
Dunham House Breaks Ground on Transformational Housing for Combat-Wounded Veterans
06/05/2025
OMAHA, Neb., May 06, 2025 (GLOBE NEWSWIRE) -- Between 2000 and 2019, the Defense and Veterans Brain Injury Center reported nearly 414,000 service members worldwide sustained a traumatic brain injury. In the same period [...]
WeightWatchers Takes Strategic Action to Eliminate $1.15 Billion of Debt, Strengthening Financial Position for Long-Term Growth and Profitability
06/05/2025
Operations continue with no impact to its more than three million members worldwide Positions the Company to execute its transformation strategy, focused on enhancing its digital and member experience and expanding its [...]
Extendicare Announces 2025 First Quarter Results
06/05/2025
MARKHAM, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2025. First Quarter 2025 Highlights Adjusted [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2025 Financial Results on May 8, 2025
06/05/2025
FREDERICK, Md., May 06, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report [...]
BetterLife Announces Debt Settlements
06/05/2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused on the development of [...]
Senti Bio Reports First Quarter 2025 Financial Results and Provides a Corporate Update on Positive SENTI-202 Clinical Development
06/05/2025
Positive Phase 1 data from lead program, SENTI-202, recently presented at the AACR Annual Meeting: SENTI-202 was generally well tolerated, preliminary RP2D identified; 4 of 7 patients achieved composite Complete [...]
WW International, Inc. Schedules Investor Conference Call
06/05/2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, announced that it will host an investor [...]
LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference
06/05/2025
SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the [...]

Pages